ProfileGDS4718 / 207221_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 26% 27% 18% 25% 23% 14% 21% 23% 32% 28% 21% 20% 22% 15% 21% 21% 22% 18% 18% 19% 24% 21% 22% 21% 19% 20% 21% 16% 18% 19% 16% 19% 28% 19% 19% 20% 20% 24% 20% 26% 21% 16% 16% 18% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3816926
GSM549102patient 115, normal, homogenized [OPG study]4.4435727
GSM549104patient 119, normal, homogenized [OPG study]4.0591818
GSM549108patient 138, normal, homogenized [OPG study]4.3742825
GSM549119patient 077, normal, homogenized [OPG study]4.2815923
GSM549133patient 032, cancer, homogenized [OPG study]3.894514
GSM549139patient 042, cancer, homogenized [OPG study]4.1595221
GSM549099patient 107, normal, homogenized [OPG study]4.2632523
GSM549109patient 139, normal, homogenized [OPG study]4.6572832
GSM549110patient 046, normal, homogenized [OPG study]4.4710928
GSM549114patient 063, normal, homogenized [OPG study]4.1411521
GSM549122patient 082, normal, homogenized [OPG study]4.1476520
GSM549134patient 033, cancer, homogenized [OPG study]4.220322
GSM549136patient 036, cancer, homogenized [OPG study]3.9067115
GSM549140patient 044, cancer, homogenized [OPG study]4.1544121
GSM549111patient 047, normal, homogenized [OPG study]4.1690521
GSM549113patient 057, normal, homogenized [OPG study]4.1530622
GSM549132patient 031, cancer, homogenized [OPG study]4.0655218
GSM549137patient 038, cancer, homogenized [OPG study]4.0650718
GSM549142patient 047, cancer, homogenized [OPG study]4.2106119
GSM549100patient 110, normal, homogenized [OPG study]4.3022824
GSM549107patient 135, normal, homogenized [OPG study]4.1350821
GSM549115patient 068, normal, homogenized [OPG study]4.1679722
GSM549116patient 072, normal, homogenized [OPG study]4.154121
GSM549120patient 078, normal, homogenized [OPG study]4.0965619
GSM549131patient 030, cancer, homogenized [OPG study]4.0854520
GSM549118patient 074, normal, homogenized [OPG study]4.1979321
GSM549129patient 027, cancer, homogenized [OPG study]4.0168216
GSM549123patient 088, normal, homogenized [OPG study]4.0718918
GSM549124patient 006, cancer, homogenized [OPG study]4.159819
GSM549126patient 015, cancer, homogenized [OPG study]3.9930216
GSM549128patient 025, cancer, homogenized [OPG study]4.0697219
GSM549103patient 117, normal, homogenized [OPG study]4.5033828
GSM549117patient 073, normal, homogenized [OPG study]4.1071219
GSM549138patient 041, cancer, homogenized [OPG study]4.0803619
GSM549141patient 045, cancer, homogenized [OPG study]4.0983820
GSM549130patient 028, cancer, homogenized [OPG study]4.1586620
GSM549101patient 111, normal, homogenized [OPG study]4.3059724
GSM549105patient 128, normal, homogenized [OPG study]4.1596820
GSM549106patient 134, normal, homogenized [OPG study]4.3431726
GSM549112patient 048, normal, homogenized [OPG study]4.182721
GSM549125patient 011, cancer, homogenized [OPG study]3.9961716
GSM549127patient 024, cancer, homogenized [OPG study]3.9638516
GSM549135patient 035, cancer, homogenized [OPG study]4.0264418